# EDGAR Filing Document

**Accession Number:** 0001782539
**File Stem:** 0001012975-25-000496
**Filing Date:** 2025-8
**Character Count:** 9015
**Document Hash:** a51f9f93edeadee92fb713aef66e68b4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001012975-25-000496.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001012975-25-000496

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nan Fung Group Holdings Ltd
- **CENTRAL INDEX KEY:** 0001782539

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D8

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-21371
- **FILM NUMBER:** 251280933

**BUSINESS ADDRESS:**
- **STREET 1:** 17TH FLOOR, AIRSIDE
- **STREET 2:** 2 CONCORDE ROAD
- **CITY:** KAI TAK
- **STATE:** K3
- **ZIP:** 00000
- **BUSINESS PHONE:** 852-2521-7417

**MAIL ADDRESS:**
- **STREET 1:** 17TH FLOOR, AIRSIDE
- **STREET 2:** 2 CONCORDE ROAD
- **CITY:** KAI TAK
- **STATE:** K3
- **ZIP:** 00000

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001782539

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Nan Fung Group Holdings Ltd

**Address:** 17TH FLOOR, AIRSIDE, KAI TAK, K3 00000

**Telephone number:** (852) 3108 3708

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-21371

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [ ] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [x] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 2

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER               | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                             | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   | SHARES VOTED FOR OR AGAINST MANAGEMENT   | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|:---|:---|:---|
| ACADIA PHARMACEUTICALS INC   | 004225108 | 05/29/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| BEONE MEDICINES LTD          | 07725L102 | 05/21/2025     | Non-binding, advisory vote on the compensation of our named executive officers, as disclosed in this Proxy Statement                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| BICYCLE THERAPEUTICS PLC     | 088786108 | 06/17/2025     | To approve, on advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement.                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| ILLUMINA INC                 | 452327109 | 05/21/2025     | Hold an advisory vote to approve the compensation provided to the "named executive officers" as disclosed in the accompanying proxy statement                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| INCYTE CORP                  | 45337C102 | 06/10/2025     | Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| KYMERA THERAPEUTICS INC      | 501575104 | 06/25/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| MADRIGAL PHARMACEUTICALS INC | 558868105 | 06/20/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the accompanying proxy statement                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| MADRIGAL PHARMACEUTICALS INC | 558868105 | 06/20/2025     | To vote, on a non-binding, advisory basis, on the frequency of future advisory votes to approve the compensation of our named executive officers                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| RECURSION PHARMACEUTICALS IN | 75629V104 | 06/18/2025     | To approve the compensation of our Named Executive Officers, as disclosed in the proxy statement accompanying this notice                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| REPLIMUNE GROUP INC          | 76029N106 | 09/04/2024     | To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| REPLIMUNE GROUP INC          | 76029N106 | 09/04/2024     | To approve, on a non-binding advisory basis, the preferred frequency of future advisory votes on the compensation of Replimune Group, Inc.'s named executive officers                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| REVOLUTION MEDICINES INC     | 76155X100 | 06/26/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay") | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| RHYTHM PHARMACEUTICALS INC   | 76243J105 | 06/24/2025     | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("Say-on-Pay Vote")                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| STANDARD BIOTOOLS INC        | 34385P108 | 06/18/2025     | Approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |

## N-PX: Signature Block

**Reporting Person:** Nan Fung Group Holdings Ltd

**By (Signature):** Tang Chun Wai Nelson

**By (Printed Signature):** Tang Chun Wai Nelson

**By (Title):** Director

**Date:** 08/29/2025